Proposed Response Parameters for Twelve‐Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings.

MLA

Foeldvari, Ivan, et al. “Proposed Response Parameters for Twelve‐Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings.” Arthritis Care & Research, vol. 75, no. 12, Dec. 2023, pp. 2453–62. EBSCOhost, https://doi.org/10.1002/acr.25171.

APA

Foeldvari, I., Torok, K. S., Anton, J., Blakley, M., Constantin, T., Curran, M., Cutolo, M., Denton, C., Fligelstone, K., Ingegnoli, F., Li, S. C., Němcová, D., Orteu, C., Pilkington, C., Smith, V., Stevens, A., Klotsche, J., Khanna, D., Costa, R. P., & Del Galdo, F. (2023). Proposed Response Parameters for Twelve‐Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings. Arthritis Care & Research, 75(12), 2453–2462. https://doi.org/10.1002/acr.25171

Chicago

Foeldvari, Ivan, Kathryn S. Torok, Jordi Anton, Michael Blakley, Tamás Constantin, Megan Curran, Maurizio Cutolo, et al. 2023. “Proposed Response Parameters for Twelve‐Month Drug Trial in Juvenile Systemic Sclerosis: Results of the Hamburg International Consensus Meetings.” Arthritis Care & Research 75 (12): 2453–62. doi:10.1002/acr.25171.